The phosphoinositide pathway of lymphoid cells: labeling after permeabilization by alveolysin, a bacterial sulfhydryl-activated cytolysin

Eur J Cell Biol. 1992 Aug;58(2):377-82.

Abstract

An improved method allowing incorporation of [3H]myo-inositol into the phosphoinositide pool of human lymphoid cells is described. The procedure devised involves cell permeabilization with a thiol-activated membranolytic toxin, alveolysin, and optimization of the phosphoinositide labeling and extraction. In these conditions 4 to 10% of the added [3H]myo-inositol is found intracellularly and half of this amount (2-5%) is incorporated into the phosphoinositide pool in only 1 h as compared to the classical 0.2 to 0.3% incorporation obtained after 10 to 20 h. The integrity of coupling between receptors and phospholipase C was assessed by the inositol phosphate production after cell stimulation by various agonists.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Burkitt Lymphoma
  • Hemolysin Proteins / pharmacology*
  • Humans
  • Inositol / metabolism
  • Inositol 1,4,5-Trisphosphate / metabolism*
  • Inositol Phosphates / metabolism*
  • Organic Chemicals
  • Signal Transduction
  • Tumor Cells, Cultured / drug effects

Substances

  • Hemolysin Proteins
  • Inositol Phosphates
  • Organic Chemicals
  • inositol 1-phosphate
  • inositol 1,4-bis(phosphate)
  • Inositol
  • alveolysin
  • Inositol 1,4,5-Trisphosphate